MarketPeel
Insider Trading Intelligence
TH

Thomas Haughey

ANIP
DIRECTOR · ANI PHARMACEUTICALS INC · CIK 0001272247
FILING MIX · LIFETIME83%/17%
BUYS
10
SELLS
2
TOTAL VALUE
$2.15M
COMPANIES
1
ACTIVE SINCE
Mar 2020
HOLDINGS NOW
38,878
AVG SELL PX
$85.46
TRADE KIND
SHOWING 12 / 12
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
4 backtested trades · 8 horizons · 2 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Thomas Haughey, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d4+25.00%-4.65%-3.75%-0.90%-1.63%
14d4+25.00%-1.43%-9.80%+8.36%+6.16%
30d4+25.00%-2.28%-7.76%+5.48%+5.35%
60d4+0.00%-8.28%-3.58%-4.70%-5.18%
90d4+0.00%-18.84%-0.20%-18.64%-19.02%
180d4+25.00%-24.84%+7.10%-31.94%-31.47%
1y4(1 pending)+0.00%-27.09%+13.07%-40.17%-61.89%
2y4(1 pending)+33.33%-6.50%+31.54%-38.04%-64.99%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ANIP · 38,878 shares · as of Jun 8, 2026
013,96627,93141,89755,862202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 10 buys / 2 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ANIP
ANI PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
2,000$80.88$161.8K38,878Jun 8, 2026Jun 10, 2026View →
ANIP
ANI PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
4,35740,878May 21, 2026Jun 10, 2026View →
ANIP
ANI PHARMACEUTICALS INC
SALE
19,341$85.93$1.66M36,521Aug 12, 2025Aug 14, 2025View →
ANIP
ANI PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
4,33655,862May 22, 2025May 27, 2025View →
ANIP
ANI PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
4,41051,526May 21, 2024May 23, 2024View →
ANIP
ANI PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
6,86547,116May 23, 2023May 24, 2023View →
ANIP
ANI PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
10,04940,251Apr 27, 2022Apr 29, 2022View →
ANIP
ANI PHARMACEUTICALS INC
PURCHASE
2,500$39.38$98.5K30,202Dec 6, 2021Dec 7, 2021View →
ANIP
ANI PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
9,29227,702Mar 23, 2021Mar 25, 2021View →
ANIP
ANI PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
7,11918,410Apr 10, 2020Apr 14, 2020View →
ANIP
ANI PHARMACEUTICALS INC
PURCHASE
3,000$45.05$135.2K11,291Mar 4, 2020Mar 5, 2020View →
ANIP
ANI PHARMACEUTICALS INC
PURCHASE
2,000$45.18$90.4K8,291Mar 3, 2020Mar 5, 2020View →
Other insiders · ANIP
Loading peer insiders…
About this filer
CIK 0001272247
ROLE
Director
PRIMARY
ANIP
COMPANIES
1
ACTIVE SINCE
Mar 2020
MARKETPEEL · /INSIDER/0001272247DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback